- Home
- BNTX vs LI Comparison
BNTX vs LI Comparison
Compare BNTX & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | LI |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 17.5B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BNTX | LI |
|---|---|---|
| Price | $100.30 | $16.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 8 |
| Target Price | ★ $137.40 | $20.91 |
| AVG Volume (30 Days) | 1.2M | ★ 4.3M |
| Earning Date | 11-03-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $3,698,814,972.00 | ★ $17,952,966,790.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | N/A | $26.33 |
| P/E Ratio | ★ N/A | $27.28 |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $81.20 | $16.11 |
| 52 Week High | $129.27 | $33.12 |
Technical Indicators
Market Signals| Indicator | BNTX | LI |
|---|---|---|
| Relative Strength Index (RSI) | 63.67 | 42.26 |
| Support Level | $95.85 | $16.82 |
| Resistance Level | $95.71 | $17.74 |
| Average True Range (ATR) | 1.88 | 0.42 |
| MACD | 0.95 | 0.15 |
| Stochastic Oscillator | 88.28 | 50.61 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.